New cholesterol drug livalozet tested in 1,500 patients
NCT ID NCT07382778
First seen Feb 03, 2026 · Last updated May 12, 2026 · Updated 14 times
Summary
This study looked at how well the drug Livalozet lowers cholesterol in people with high cholesterol, comparing those who also have diabetes to those who don't. Over 1,500 adults took part, and the main goal was to see how much their LDL (bad) cholesterol dropped after 24 weeks. The results help doctors understand if Livalozet works differently for people with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13496, South Korea
Conditions
Explore the condition pages connected to this study.